BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33126827)

  • 21. Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.
    Nitzsche B; Gloesenkamp C; Schrader M; Hoffmann B; Zengerling F; Balabanov S; Honecker F; Höpfner M
    Br J Cancer; 2012 Nov; 107(11):1853-63. PubMed ID: 23169338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors.
    Hsieh TH; Liu YR; Chang TY; Liang ML; Chen HH; Wang HW; Yen Y; Wong TT
    Neuro Oncol; 2018 Mar; 20(4):519-530. PubMed ID: 29036598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1).
    Lind GE; Skotheim RI; Fraga MF; Abeler VM; Esteller M; Lothe RA
    J Pathol; 2006 Dec; 210(4):441-9. PubMed ID: 17029216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
    Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
    Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epigenome of testicular germ cell tumors.
    Lind GE; Skotheim RI; Lothe RA
    APMIS; 2007 Oct; 115(10):1147-60. PubMed ID: 18042148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-scale CRISPR screen reveals neddylation to contribute to cisplatin resistance of testicular germ cell tumours.
    Funke K; Einsfelder U; Hansen A; Arévalo L; Schneider S; Nettersheim D; Stein V; Schorle H
    Br J Cancer; 2023 Jun; 128(12):2270-2282. PubMed ID: 37024667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation similarities of two CpG sites within exon 5 of human H19 between normal tissues and testicular germ cell tumours of adolescents and adults, without correlation with allelic and total level of expression.
    Gillis AJ; Verkerk AJ; Dekker MC; van Gurp RJ; Oosterhuis JW; Looijenga LH
    Br J Cancer; 1997; 76(6):725-33. PubMed ID: 9310237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation profile of DNA repetitive elements in human testicular germ cell tumor.
    Ushida H; Kawakami T; Minami K; Chano T; Okabe H; Okada Y; Okamoto K
    Mol Carcinog; 2012 Sep; 51(9):711-22. PubMed ID: 21809391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles.
    Duale N; Lindeman B; Komada M; Olsen AK; Andreassen A; Soderlund EJ; Brunborg G
    Mol Cancer; 2007 Aug; 6():53. PubMed ID: 17711579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of DNA-methyltransferase 3A expression is associated with hypomethylation of intron 25 in human testicular germ cell tumors.
    Ishii T; Kohu K; Yamada S; Ishidoya S; Kanto S; Fuji H; Moriya T; Satake M; Arai Y
    Tohoku J Exp Med; 2007 Jun; 212(2):177-90. PubMed ID: 17548962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation.
    McCabe MT; Lee EK; Vertino PM
    Cancer Res; 2009 Jan; 69(1):282-91. PubMed ID: 19118013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
    Selfe J; Goddard NC; McIntyre A; Taylor KR; Renshaw J; Popov SD; Thway K; Summersgill B; Huddart RA; Gilbert DC; Shipley JM
    J Pathol; 2018 Feb; 244(2):242-253. PubMed ID: 29160922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors.
    Schmidtova S; Kalavska K; Kucerova L
    Curr Oncol Rep; 2018 Sep; 20(11):88. PubMed ID: 30259297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
    Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
    Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
    Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
    Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypermethylation of the 5' CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis.
    Manton KJ; Douglas ML; Netzel-Arnett S; Fitzpatrick DR; Nicol DL; Boyd AW; Clements JA; Antalis TM
    Br J Cancer; 2005 Feb; 92(4):760-9. PubMed ID: 15685234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetics: a way to understand the origin and biology of testicular germ cell tumors.
    Okamoto K
    Int J Urol; 2012 Jun; 19(6):504-11. PubMed ID: 22375557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent.
    Piulats JM; Vidal A; García-Rodríguez FJ; Muñoz C; Nadal M; Moutinho C; Martínez-Iniesta M; Mora J; Figueras A; Guinó E; Padullés L; Aytés À; Molleví DG; Puertas S; Martínez-Fernández C; Castillo W; Juliachs M; Moreno V; Muñoz P; Stefanovic M; Pujana MA; Condom E; Esteller M; Germà JR; Capella G; Farré L; Morales A; Viñals F; García-Del-Muro X; Cerón J; Villanueva A
    Clin Cancer Res; 2018 Aug; 24(15):3755-3766. PubMed ID: 29618620
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.